Skip to content

Clinical trials

Withdrawn Phase 2 Leukemia, Myelomonocytic, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Phase 2 Status: Withdrawn Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20201
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center1
Janssen Research & Development, LLC1
M.D. Anderson Cancer Center1
Sensei Biotherapeutics, Inc.1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic5
Myelodysplastic Syndromes4
Leukemia, Myeloid, Acute2
Leukemia, Myeloid, Chronic-Phase2
Lymphoma, Non-Hodgkin2
Myeloproliferative Disorders2
Primary Myelofibrosis2
Anemia1
Blast Crisis1
Burkitt Lymphoma1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.